View free online video of the International Ask the Experts session held in Orlando on 9 December 2015 at the International Alliance of ALS/MND Association Meeting. Lucie Bruijn, PhD, MBA, The ALS Association's Chief Scientist, discusses new research projects followed by an international panel discussion.
View the video here on the MND NSW YouTube channel
Joining Dr. Bruijn on the panel:
• Richard Bedlack MD, PhD, MS. Dr. Bedlack is Associate Professor of Neurology and Director, Duke ALS Clinic. He also leads ALS Untangled, a network of physicians and researchers investigating alternative and off-label treatments for ALS. Dr. Bedlack's recent research also resulted in the identification of a newly associated gene, which is thought to play a role in inflammations and damaged cell clearance associated with ALS.
• Michael Benatar, MD, PhD. Dr. Benatar is Professor of Neurology and the Chief of the Neuromuscular Division in the Department of Neurology at the University of Miami. He is the first incumbent of the Walter Bradley Chair in ALS Research. With a focus on familial ALS and genetics, Dr. Benatar leads the CReATe Research Consortium which investigates the relationship between phenotype and genotype in ALS and the development of biomarkers that might be useful in therapy development.
• Ammar Al-Chalabi, MD. Professor of Neurology and Complex Disease Genetics, and Director of King's MND Care and Research Centre at King's College in London. Dr. Al-Chalabi's research focuses on understanding what causes or modifies ALS as a way of finding new, effective treatments. His studies involve genes, lifestyle and the different clinical patterns of ALS. Dr. Al-Chalabi's current research studies investigate the genetic susceptibility in ALS, and the relationship between cognitive changes and physical symptoms in ALS.